NL-OMON55009撤回2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection * a human challenge study - CHIMP
niversitair Medisch Centrum Utrecht0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Healthy males or females
- •2. Age 18-55 years
- •3. Signed and dated informed consent form
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •1. Child <3 years old living in subject*s household
- •2. Presence of significant acute or chronic medical illness that is associated
- •with increased risk of respiratory viral illness related complications. These
- •include but are not limited to:
- •a. Recent (within adulthood) history of asthma, COPD, hypertension,
- •reactive airway disease, or any other chronic lung illness
- •b. History or evidence of impaired immune responsivity or autoimmune
- •c. Confirmed hepatitis B (HBV), human immunodeficiency virus (HIV), or
- •hepatitis C (HCV) test
- •3. Adults with a nasal cold or obstructions which could interfere with
- •administration of the study intervention
- •4. Simultaneous use of other nasal drops, sprays, or medications
- •5. Nasal surgery prior to or during the trial
- •6. Positive COVID-test <48 hours prior to start of the study
研究者
相似试验
进行中（未招募）
1 期
asal administration of palivizumab in an RSV human challenge modelrespiratory syncytial virus infectionEUCTR2020-004137-21-NLniversity Medical Center Utrecht34
招募中
2 期
Effect of intranasal administration of palivizumab on experimental respiratory syncytial viral infection - a controlled human infection studyRSV respiratory tract infection1004743810024970bronchiolitisNL-OMON54420niversitair Medisch Centrum Utrecht34
进行中（未招募）
1 期
asal administration of palivizumab to prevent respiratory syncytial virus infectiorespiratory syncytial virus infectionEUCTR2018-002742-37-NLniversity Medical Center Utrecht408
Unknown
不适用
asal administration of palivizumab toprevent RSV infectioRespiratory Syncytial Virus (RSV), Palivizumab, respiratoir syncytieel virus (RSV)NL-OMON23402niversity Medical Center Utrecht348
已完成
2 期
Effect of mepolizumab in eosinophilic chronic rhinosinusitisChronic rhinosinusitisACTRN12618000113257Richard Harvey20